The global in vitro toxicology testing market will reach $17,227 million by 2018 growing at a double-digit CAGR during the forecast period (2013–2018).
Dallas, Texas (PRWEB) April 05, 2014
Attributed to the support offered by the European government, the in vitro toxicology testing market in Europe was the largest in 2013 and is expected to hold the same stance by 2018
There has been a substantial rise in the costs to develop a new pharmaceutical product in recent years. This is specially observed when a new compound enters animal testing and clinical trials. The use of animals in experimentation is becoming dearer, primarily due to the costs involved in breeding and acquisition of animals, due to the complexity of procedures involved in the in vivo testing, and several other ethical issues including concerns for animal welfare. Moreover the rates of drug attrition have also risen in recent years due to lesser availability of data on the toxicity profiles of the candidates that are under development process. To counteract these issues there has been a rise in the development of in vitro methods that are alternative to animal testing. A paradigm shift is observed towards emerging technologies such as assays based on human cells or non-mammalian models, high throughput testing, omics approaches, ex vivo models, and in silico techniques.
Complete Report available at http://www.rnrmarketresearch.com/in-vitro-toxicology-toxicity-testing-market-by-industry-diagnostic-pharmaceutical-cosmetics-chemical-technology-cell-culture-hts-omics-applications-systemic-dermal-ocular-method-cell-market-report.html.
Pharmaceutical industry was the largest segment in the in vitro toxicology testing market which is expected to hold the leading position in the coming five years. This is largely attributed to the widely recognized factors of evaluation of the toxicity levels in the early stages of development that necessitates the use of in vitro methods to improve the drug toxicity profiles. On the other hand, cosmetic industry will be the fastest growing industry in the coming years as a result of the huge government support in Europe to ban the use of animals for testing the toxic effects of beauty products. The European government has also forbidden the marketing of those cosmetics product which were tested on animals.
For better interpretation of in vitro results cell culture technology involving cell based assays has emerged as a momentous technology that has been driving the in vitro toxicology testing market. With the advancement in the cell culture technology a number of cell models are emerging that provide insights into the biochemical and signaling process that better interprets the in vitro data. With the increasing demand of emergent 3D models the cell culture technology is estimated to be the fastest growing technology in the next five years.
With the implementation of several laws through adoption of various initiatives by the European government to stop animal testing; the European region is the leading market. The government promotes the use of in vitro techniques through launch of programs such as AXLR8 for the purpose of monitoring EU funded 3Rs research activities with the aim of accelerating the transition from in vivo testing to in vitro testing. The emerging countries in Asia such as China and India will register high growth in the coming years, this can be attributed to the low development costs offered by these nations. Moreover due to the economic growth of these nations there has been a rise in the investments in these countries which is further propelling the market in a positive direction.
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=163384.
The grey area while estimating the market size was the overlapping nature of the applications while segregating them based on evaluation of endpoints involved. These included testing of end points such as acute systemic toxicity, pharmacokinetics & metabolism, repeated dose/organ toxicity under systemic toxicity, dermal penetration, skin irritation/corrosion and skin sensitization under dermal toxicity. This was later clarified with the help of various experts that participated during the study.
From an insight perspective, this research report focuses on the qualitative data, market size, share, growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market shares, sizes, and related growth of various segments in the industry. It also focuses on the emerging and high-growth segments of in vitro toxicology testing market, high-growth regions, and the initiatives of respective governments.
The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the in-vitro toxicology testing market, product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Browse more reports on In Vitro Diagnostics (IVD) Market at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd.
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.